Scope and Design of the Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements (FREEDOM) Study

American Journal of Kidney Diseases

Volumn 53, Issue 2, 2009, Pages 310-320

  Jaber, Bertrand L ^a   Finkelstein, Fredric O ^b   Glickman, Joel D ^c   Hull, Alan R ^d   Kraus, Michael A ^e   Leypoldt, John K ^f   Liu, Jiannong ^g   Gilbertson, David ^g   McCarthy, James ^h   Miller, Brent W ⁱ   Moran, John ^j   Collins, Allan J ^k  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Renal Management Inc   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF UTAH   (United States)

^g MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^h Mayo Clinic College of Medicine   (United States)

ⁱ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j CA   (United States)

^k UNIVERSITY OF MINNESOTA   (United States)

more..

Author keywords

cost effectiveness; daily dialysis; End stage renal disease (ESRD); hemodialysis; quality of life

Indexed keywords

UREA;

ADULT; AGED; ANEMIA; ARTICLE; BONE METABOLISM; CONTROLLED STUDY; DATA BASE; DIALYSIS EQUIPMENT AND SUPPLIES; FOLLOW UP; HEALTH CARE COST; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; KIDNEY DISEASE; LIFE EXPECTANCY; MEDICARE; METHODOLOGY; MINERAL METABOLISM; NUTRITION; QUALITY OF LIFE; SAMPLE SIZE; VASCULAR ACCESS;

HUMANS; KIDNEY FAILURE, CHRONIC; QUALITY OF LIFE; QUESTIONNAIRES; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 58249108296     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.07.013     Document Type: Article

References (72)

1. US Renal Data System. USRDS 2006 Annual Data Report (2006), The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
2. Finkelstein F.O., Sorkin M., Cramton C.W., and Nolph K. Initiatives in peritoneal dialysis: Where do we go from here?. Perit Dial Int 11 (1991) 274-278
3. Davies S.J., and Brown E.A. EAPOS: What have we learned?. Perit Dial Int 27 (2007) 131-135
4. Winkelmayer W.C., Glynn R.J., Mittleman M.A., Levin R., Pliskin J.S., and Avorn J. Comparing mortality of elderly patients on hemodialysis versus peritoneal dialysis: A propensity score approach. J Am Soc Nephrol 13 (2002) 2353-2362
5. Jaar B.G., Coresh J., Plantinga L.C., et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med 143 (2005) 174-183
6. Xue J.L., Everson S.E., Constantini E.G., et al. Peritoneal and hemodialysis: II. Mortality risk associated with initial patient characteristics. Kidney Int 61 (2002) 741-746
7. Eknoyan G., Beck G.J., Cheung A.K., et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347 (2002) 2010-2019
8. Paniagua R., Amato D., Vonesh E., et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13 (2002) 1307-1320
9. Kjellstrand C.M., Rosa A.A., Shideman J.R., Rodrigo F., Davin T., and Lynch R.E. Optimal dialysis frequency and duration: The "unphysiology hypothesis". Kidney Int Suppl 8 (1978) S120-S124
10. Buoncristiani U. Fifteen years of clinical experience with daily haemodialysis. Nephrol Dial Transplant 13 suppl 6 (1998) S148-S151
11. Lopot F., and Valek A. Quantification of dialysis unphysiology. Nephrol Dial Transplant 13 suppl 6 (1998) S74-S78
12. Levey A.S., Beto J.A., Coronado B.E., et al., National Kidney Foundation Task Force on Cardiovascular Disease. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here?. Am J Kidney Dis 32 (1998) 853-906
13. Ting G. The strategic role of daily hemodialysis in managed care in the United States. Semin Dial 13 (2000) 385-388
14. Fagugli R.M., Reboldi G., Quintaliani G., et al. Short daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients. Am J Kidney Dis 38 (2001) 371-376
15. Galland R., Traeger J., Arkouche W., Delawari E., and Fouque D. Short daily hemodialysis and nutritional status. Am J Kidney Dis 37 suppl 2 (2001) S95-S98
16. Galland R., Traeger J., Arkouche W., Cleaud C., Delawari E., and Fouque D. Short daily hemodialysis rapidly improves nutritional status in hemodialysis patients. Kidney Int 60 (2001) 1555-1560
17. Lockridge Jr. R.S. Daily dialysis and long-term outcomes-The Lynchburg Nephrology NHHD experience. Nephrol News Issues 13 (1999) 9, 16, 23-26
18. Pierratos A. Nocturnal home haemodialysis: An update on a 5-year experience. Nephrol Dial Transplant 14 (1999) 2835-2840
19. Pierratos A. Daily hemodialysis: An update. Curr Opin Nephrol Hypertens 11 (2002) 165-171
20. Kjellstrand C.M., Buoncristiani U., Ting G., et al. Short daily haemodialysis: Survival in 415 patients treated for 1006 patient-years. Nephrol Dial Transplant (2008) May 5 (Epub ahead of print)
21. Lockridge Jr. R.S., and Moran J. Short daily hemodialysis and nocturnal hemodialysis at home: Practical considerations. Semin Dial 21 (2008) 49-53
22. Walsh M., Culleton B., Tonelli M., and Manns B. A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int 67 (2005) 1500-1508
23. Bergman A., Fenton S., Richardson R., and Chan C. Reduction in cardiovascular related hospitalization with nocturnal home hemodialysis. Clin Nephrol 69 (2008) 33-39
24. Uldall R., Ouwendyk M., Francoeur R., et al. Slow nocturnal home hemodialysis at the Wellesley Hospital. Adv Ren Replace Ther 3 (1996) 133-136
25. Mucsi I., Hercz G., Uldall R., Ouwendyk M., Francoeur R., and Pierratos A. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 53 (1998) 1399-1404
26. Kooistra M.P., Vos J., Koomans H.A., and Vos P.F. Daily home haemodialysis in The Netherlands: Effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant 13 (1998) 2853-2860
27. Lindsay R.M., Alhejaili F., Nesrallah G., et al. Calcium and phosphate balance with quotidian hemodialysis. Am J Kidney Dis 42 suppl 1 (2003) S24-S29
28. Lockridge R.J., Spencer M., Craft V., et al. Nightly home hemodialysis: Five and one-half years of experience in Lynchburg, Virginia. Hemodial Int 8 (2004) 61-69
29. Achinger S.G., and Ayus J.C. The role of daily dialysis in the control of hyperphosphatemia. Kidney Int Suppl 95 (2005) S28-S32
30. Toussaint N., Boddington J., Simmonds R., Waldron C., Somerville C., and Agar J. Calcium phosphate metabolism and bone mineral density with nocturnal hemodialysis. Hemodial Int 10 (2006) 280-286
31. Suri R.S., Nesrallah G.E., Mainra R., et al. Daily hemodialysis: A systematic review. Clin J Am Soc Nephrol 1 (2006) 33-42
32. Hanly P.J., and Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 344 (2001) 102-107
33. Hanly P., Chan C., and Pierratos A. The impact of nocturnal hemodialysis on sleep apnea in ESRD patients. Nephrol News Issues 17 (2003) 19-21
34. Beecroft J., Hoffstein V., Pierratos A., Chan C., McFarlane P., and Hanly P. Nocturnal haemodialysis increases pharyngeal size in patients with sleep apnoea and end-stage renal disease. Nephrol Dial Transplant 23 (2008) 673-679
35. Culleton B.F., Walsh M., Klarenbach S.W., et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: A randomized controlled trial. JAMA 298 (2007) 1291-1299
36. Traeger J., Sibai-Galland R., Delawari E., and Arkouche W. Daily versus standard hemodialysis: One year experience. Artif Organs 22 (1998) 558-563
37. Ayus J.C., Mizani M.R., Achinger S.G., Thadhani R., Go A.S., and Lee S. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: A prospective, controlled study. J Am Soc Nephrol 16 (2005) 2778-2788
38. Buoncristiani U., Fagugli R.M., Pinciaroli M.R., Kulurianu H., Ceravolo G., and Bova C. Reversal of left-ventricular hypertrophy in uremic patients by treatment with daily hemodialysis. Contrib Nephrol 119 (1996) 152-156
39. Vos P.F., Zilch O., and Kooistra M.P. Clinical outcome of daily dialysis. Am J Kidney Dis 37 suppl 2 (2001) S99-S102
40. Lindsay R.M., Leitch R., Heidenheim A.P., and Kortas C. The London Daily/Nocturnal Hemodialysis Study-Study design, morbidity, and mortality results. Am J Kidney Dis 42 suppl 1 (2003) S5-S12
41. Ayus J.C., Achinger S.G., Mizani M.R., et al. Phosphorus balance and mineral metabolism with 3 h daily hemodialysis. Kidney Int 71 (2007) 336-342
42. Shurraw S., and Zimmerman D. Vascular access complications in daily dialysis: A systematic review of the literature. Minerva Urol Nefrol 57 (2005) 151-163
43. Twardowski Z.J. Daily dialysis: Is this a reasonable option for the new millennium?. Nephrol Dial Transplant 16 (2001) 1321-1324
44. Mohr P.E., Neumann P.J., Franco S.J., Marainen J., Lockridge R., and Ting G. The case for daily dialysis: Its impact on costs and quality of life. Am J Kidney Dis 37 (2001) 777-789
45. Mohr P.E., Neumann P.J., Franco S.J., Marainen J., Lockridge R., and Ting G. The quality of life and economic implications of daily dialysis. Policy Anal Brief H Ser 1 (1999) 1-4
46. Mohr P.E. The economics of daily dialysis. Adv Ren Replace Ther 8 (2001) 273-279
47. Suri R.S., Garg A.X., Chertow G.M., et al. Frequent Hemodialysis Network (FHN) randomized trials: Study design. Kidney Int 71 (2007) 349-359
48. Ware J., and Sherbourne C. The MOS 36-Item Short-Form Health Survey (SF-36). Med Care 30 (1992) 473-481
49. Ware J., Snow K., Kosinske M., and Gandek B. SF-36 Health Survey, Manual and Interpretation Guide (1993), Nimrod, Boston, MA
50. Beck A. Depression: Causes and Treatment (1972), University of Pennsylvania, Philadelphia, PA
51. Ambrosini P., Metz C., Bianchi M., Rabinovich H., and Undie A. Concurrent validity and psychometric properties of the Beck Depression Inventory in outpatient adolescents. J Am Acad Child Adolesc Psychiatry 30 (1991) 51-57
52. Brown G., Hammen C., Craske M., and Wickens T. Dimensions of dysfunctional attitudes as vulnerabilities to depressive symptoms. J Abnorm Psychol 104 (1995) 431-435
53. Walters A.S., LeBrocq C., Dhar A., et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 4 (2003) 121-132
54. Allen R.P., Kushida C.A., and Atkinson M.J. Factor analysis of the International Restless Legs Syndrome Study Group's scale for restless legs severity. Sleep Med 4 (2003) 133-135
55. Hays R., and Stewart A. Sleep measures. In: Stewart A., and Ware Jr. J. (Eds). Measuring Functioning and Well Being: The Medical Outcomes Study Approach (1992), Duke University, Durham, NC 235-259
56. Hays R.D., Martin S.A., Sesti A.M., and Spritzer K.L. Psychometric properties of the Medical Outcomes Study sleep measure. Sleep Med 6 (2005) 41-44
57. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Hemodialysis Adequacy, 2000. Am J Kidney Dis 37 suppl 1 (2001) S7-S64
58. Gotch F.A. The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 13 suppl 6 (1998) S10-S14
59. Leypoldt J., Jaber B., and Zimmerman D. Calculation of standard Kt/V with corrections for post-dialysis urea rebound. Hemodial Int 7 (2003) 80 abstr
60. Nesrallah G.E., Moist L.M., Awaraji C., and Lindsay R.M. An international registry to compare quotidian dialysis regimens with conventional thrice-weekly hemodialysis: Why, how, and potential pitfalls. Semin Dial 17 (2004) 131-135
61. US Renal Data System: USRDS 2005 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2005
62. Hebert P.L., Geiss L.S., Tierney E.F., Engelgau M.M., Yawn B.P., and McBean A.M. Identifying persons with diabetes using Medicare claims data. Am J Med Qual 14 (1999) 270-277
63. O'Brien P., and Fleming T. A multiple testing procedure for clinical trials. Biometrics 35 (1979) 549-556
64. Jaber B.L., Zimmerman D.L., Teehan G.S., et al. Daily hemofiltration for end-stage renal disease: A feasibility and efficacy trial. Blood Purif 22 (2004) 481-489
65. Lindsay R.M., Heidenheim P.A., Nesrallah G., Garg A.X., and Suri R. Minutes to recovery after a hemodialysis session: A simple health-related quality of life question that is reliable, valid, and sensitive to change. Clin J Am Soc Nephrol 1 (2006) 952-959
66. Troidle L., Hotchkiss M., and Finkelstein F. A thrice weekly in-center nocturnal hemodialysis program. Adv Chronic Kidney Dis 14 (2007) 244-248
67. Samsa G., Edelman D., Rothman M.L., Williams G.R., Lipscomb J., and Matchar D. Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 15 (1999) 141-155
68. Wuerth D., Finkelstein S.H., Ciarcia J., Peterson R., Kliger A.S., and Finkelstein F.O. Identification and treatment of depression in a cohort of patients maintained on chronic peritoneal dialysis. Am J Kidney Dis 37 (2001) 1011-1017
69. Troidle L., Wuerth D., Finkelstein S., Kliger A., and Finkelstein F. The BDI and the SF36: Which tool to use to screen for depression?. Adv Perit Dial 19 (2003) 159-162
70. Troidle L., Watnick S., Wuerth D.B., Gorban-Brennan N., Kliger A.S., and Finkelstein F.O. Depression and its association with peritonitis in long-term peritoneal dialysis patients. Am J Kidney Dis 42 (2003) 350-354
71. Reynolds J.T., Homel P., Cantey L., et al. A one-year trial of in-center daily hemodialysis with an emphasis on quality of life. Blood Purif 22 (2004) 320-328
72. Quilici S., Abrams K.R., Nicolas A., et al. Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome. Sleep Med (2008) Jan 26 (Epub ahead of print)